Molecular optical imaging: Applications leading to the development of present day therapeutics
暂无分享,去创建一个
[1] David J. Brooks,et al. Positron emission tomography and single-photon emission computed tomography in central nervous system drug development , 2005, NeuroRX.
[2] Brian D. Ross,et al. Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making , 2005, NeuroRX.
[3] Gary H. Glover,et al. Foundations of advanced magnetic resonance imaging , 2005, NeuroRX.
[4] Ralph Weissleder,et al. Glioma therapy and real‐time imaging of neural precursor cell migration and tumor regression , 2005, Annals of neurology.
[5] M. Devous. Single-photon emission computed tomography in neurotherapeutics , 2005 .
[6] A. Söling,et al. A dual function fusion protein of Herpes simplex virus type 1 thymidine kinase and firefly luciferase for noninvasive in vivo imaging of gene therapy in malignant glioma , 2004, Genetic vaccines and therapy.
[7] R. Weissleder,et al. Molecular imaging of gene therapy for cancer , 2004, Gene Therapy.
[8] R. Weissleder,et al. Molecular Imaging of Factor XIIIa Activity in Thrombosis Using a Novel, Near-Infrared Fluorescent Contrast Agent That Covalently Links to Thrombi , 2004, Circulation.
[9] R. Weissleder,et al. Adenovirus-Mediated Expression of Antisense Urokinase Plasminogen Activator Receptor and Antisense Cathepsin B Inhibits Tumor Growth, Invasion, and Angiogenesis in Gliomas , 2004, Cancer Research.
[10] R. Weissleder,et al. Inducible release of TRAIL fusion proteins from a proapoptotic form for tumor therapy. , 2004, Cancer research.
[11] Ralph Weissleder,et al. A novel method for imaging apoptosis using a caspase-1 near-infrared fluorescent probe. , 2004, Neoplasia.
[12] R. Weissleder,et al. In Vivo Imaging of HIV Protease Activity in Amplicon Vector-transduced Gliomas , 2004, Cancer Research.
[13] Ralph Weissleder,et al. Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo , 2003, Oncogene.
[14] C. Gondi,et al. Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis , 2003, Oncogene.
[15] Ralph Weissleder,et al. In vivo tracking of neural progenitor cell migration to glioblastomas. , 2003, Human gene therapy.
[16] Vasilis Ntziachristos,et al. Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy. , 2003, Neoplasia.
[17] Thomas L. Chenevert,et al. Noninvasive real-time imaging of apoptosis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[18] Melitta Schachner,et al. Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons , 2002, Nature Biotechnology.
[19] C. Contag,et al. It's not just about anatomy: In vivo bioluminescence imaging as an eyepiece into biology , 2002, Journal of magnetic resonance imaging : JMRI.
[20] John Calvin Reed,et al. Apoptosis-based therapies , 2002, Nature Reviews Drug Discovery.
[21] Thomas L. Chenevert,et al. Molecular Imaging of Gene Expression and Efficacy following Adenoviral-Mediated Brain Tumor Gene Therapy , 2002 .
[22] R Weissleder,et al. Molecular imaging. , 2009, Radiology.
[23] S. Gambhir,et al. Optical imaging of Renilla luciferase reporter gene expression in living mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[24] S S Gambhir,et al. Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[25] B. Rice,et al. In vivo imaging of light-emitting probes. , 2001, Journal of biomedical optics.
[26] E. Galun,et al. Imaging transgene expression in live animals. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[27] In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy , 2001, Nature Medicine.
[28] Ralph Weissleder,et al. In vivo molecular target assessment of matrix metalloproteinase inhibition , 2001, Nature Medicine.
[29] P. Williamson,et al. Phosphatidylserine, a death knell , 2001, Cell Death and Differentiation.
[30] W. Semmler,et al. Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands , 2001, Nature Biotechnology.
[31] P. Black,et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[32] R Weissleder,et al. In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. , 2000, Cancer research.
[33] A. Boveris,et al. Nitric oxide production and mitochondrial dysfunction during rat thymocyte apoptosis. , 2000, Archives of biochemistry and biophysics.
[34] T. Billiar,et al. Cellular Non-heme Iron Content Is a Determinant of Nitric Oxide-mediated Apoptosis, Necrosis, and Caspase Inhibition* , 2000, The Journal of Biological Chemistry.
[35] A. Jacobs,et al. Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.
[36] C. Contag,et al. Use of reporter genes for optical measurements of neoplastic disease in vivo. , 2000, Neoplasia.
[37] C. Contag,et al. Visualizing the kinetics of tumor-cell clearance in living animals. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[38] R Weissleder,et al. Preparation of a cathepsin D sensitive near-infrared fluorescence probe for imaging. , 1999, Bioconjugate chemistry.
[39] L. Matrisian,et al. Measurement of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Blood and Tissues: Clinical and Experimental Applications , 1999, Annals of the New York Academy of Sciences.
[40] V. Yee,et al. Blood coagulation factor XIII: structure and function. , 1999, Thrombosis research.
[41] Charles D. McDermott,et al. Broad Antitumor and Antiangiogenic Activities of AG3340, a Potent and Selective MMP Inhibitor Undergoing Advanced Oncology Clinical Trials , 1999, Annals of the New York Academy of Sciences.
[42] V. Dixit,et al. Apoptosis control by death and decoy receptors. , 1999, Current opinion in cell biology.
[43] R. Weissleder,et al. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.
[44] Y. Lazebnik,et al. Caspases: enemies within. , 1998, Science.
[45] R Weissleder,et al. Preclinical evaluation and phase I clinical trial of a 99mTc-labeled synthetic polymer used in blood pool imaging. , 1998, AJR. American journal of roentgenology.
[46] M A Moses,et al. Increased incidence of matrix metalloproteinases in urine of cancer patients. , 1998, Cancer research.
[47] C. Stiles. Cancer of the central nervous system. Review of an AACR special conference in cancer research with the joint section on tumors of the AANS/CNS (San Diego, CA, June 7-11, 1997). , 1998, Biochimica et biophysica acta.
[48] H K Rooprai,et al. Proteases and their inhibitors in human brain tumours: a review. , 1997, Anticancer research.
[49] William G. Stetler-Stevenson,et al. Matrix Metalloproteinases , 1997, Drugs & aging.
[50] R. Gentz,et al. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. , 1997, Science.
[51] R. Kreis,et al. Dipolar resonance frequency shifts in 1H MR spectra of skeletal muscle: Confirmation in rats at 4.7 T in Vivo and observation of changes postmortem , 1997, Magnetic resonance in medicine.
[52] Nicole Nelson,et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells , 1997, Nature.
[53] C A Smith,et al. Identification and characterization of a new member of the TNF family that induces apoptosis. , 1995, Immunity.
[54] J. Mullins,et al. Photonic detection of bacterial pathogens in living hosts , 1995, Molecular microbiology.
[55] A. Hanby,et al. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. , 1993, Cancer research.
[56] M. Stearns,et al. Type IV collagenase (M(r) 72,000) expression in human prostate: benign and malignant tissue. , 1993, Cancer research.
[57] K. O. Elliston,et al. A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes , 1992, Nature.
[58] C. Cepko,et al. Multipotent neural cell lines can engraft and participate in development of mouse cerebellum , 1992, Cell.